Table 2.
Systematic review/meta‐analyses based on clinical trials of curcumin for human data
| Disease | Publications analysed | Outcome | References |
|---|---|---|---|
| Skin health | PubMed and Embase till Aug 2015 | Benefits skin health | Vaughn et al., 2016 |
| Depressive disorder | Literature until Aug 2015 | Reduces depressive symptoms | Al‐Karawi et al., 2016 |
| Circulating TNF‐α | PubMed‐Medline, Scopus, Web of Science, Google Scholar till Sep 2015 | Lowers circulating TNF‐α | Sahebkar et al., 2016 |
| Painful conditions | Literature till Sep 2014 | Safe and effective | Sahebkar and Henrotin, 2016 |
| Musculoskeletal pain | CINAHL, Embase, CENTRAL, PubMed, Scopus, PsycINFO, Clinicaltrials.gov, unpublished studies | Analysis not completed | Gaffey et al., 2015 |
| IBD | Cochrane Library, Pubmed/Medline, PsychINFO, Scopus through Mar 2014 | Effective | Langhorst et al., 2015 |
| Dementia | Medline, Embase, Cochrane till Jul 2013 | Safe (Short term use) | Brondino et al., 2014 |
| Diabetes | Medline database in 2013 | Effective | Zhang et al., 2013 |
| Blood lipid levels | PubMed‐Medline, Scopus, Ovid‐AMED, Clinical trial registry, Cochrane through Sep 2012 | No effect | Sahebkar, 2014a |
| Malignant disorders | PubMed, Google J‐Gate | – | Ara et al., 2016 |
| Analgesic efficacy and safety | Scopus and Medline till Sep 2014 | Safe and effective | Sahebkar and Henrotin, 2016 |
| Circulating CRP levels | PubMed/Medline and Scopus | Reduces circulating CRP levels | Sahebkar, 2014b |
CENTRA, Cochrane Central Register of Controlled Trials; CRP, c‐reactive protein; IBD, inflammatory bowel disease